1-2 of 2
Patrick Mansky, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Weekly Temsirolimus and Bortezomib For Relapsed Or Refractory B-Cell Non-Hodgkin Lymphoma: A Wisconsin Oncology Network Phase II Study

Timothy S. Fenske, MD, KyungMann Kim, PhD, Chong Zhang, MS, John P. Farnen, MD, FACP, Adedayo A. Onitilo, MD, Jules H. Blank, MD, Harish Ahuja, MD, Tim Wassenaar, MD, Rubina Qamar, MD, Patrick Mansky, MD, Anne Traynor, MD, Ryan J. Mattison, MD, Brad S. Kahl, MD
Journal: Blood
Blood (2013) 122 (21): 3035.
https://doi.org/10.1182/blood.V122.21.3035.3035
Published: 2013
Journal Articles

Bendamustine + Rituximab (BR) Chemoimmunotherapy and Maintenance Lenalidomide in Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL): A Wisconsin Oncology Network (WON) Study

Julie E. Chang, MD, Chong Zhang, KyungMann Kim, PhD, Rachel Kirby, Lynn Volk, Jae Werndli, Ronald S. Go, MD, Matthias Weiss, MD, PhD, Jules H. Blank, MD, Michael A. Thompson, MD, PhD, John P. Farnen, MD, FACP, Craig E. Cole, MD, Ali W. Bseiso, MBBS, Michael Volk, MD, Gerald Bayer, MD, Tim Wassenaar, MD, Patrick Mansky, MD, Anne Traynor, Timothy S. Fenske, MD, Brad S. Kahl, M.D.
Journal: Blood
Blood (2012) 120 (21): 3647.
https://doi.org/10.1182/blood.V120.21.3647.3647
Published: 2012